Idorsia Ltd (SWX:IDIA)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.555
-0.055 (-1.52%)
Apr 2, 2026, 2:30 PM CET

Revenue by Segment

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Innovative Medicines for Unmet Medical Needs
220.58M112.51M152.39M97.10M35.35M
Innovative Medicines for Unmet Medical Needs Growth
96.06%-26.17%56.93%174.70%-50.74%
Total
220.58M112.51M152.39M97.10M35.35M
Total Growth
96.06%-26.17%56.93%174.70%-50.74%

Revenue by Geography

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Switzerland
90.74M51.11M88.03M46.58M35.35M
Switzerland Growth
77.53%-41.94%88.99%31.77%-50.74%
United States
26.99M28.60M24.41M5.54M-
United States Growth
-5.62%17.17%340.36%--
France
67.43M11.98M---
France Growth
462.78%----
EUCAN
35.42M20.81M6.28M1.00M-
EUCAN Growth
70.16%231.21%525.90%--
Japan
--33.66M43.98M-
Japan Growth
---23.45%--
Total
220.58M112.51M152.39M97.10M35.35M
Total Growth
96.06%-26.17%56.93%174.70%-50.74%
Source: S&P Global Market Intelligence.